AZRX Azurrx Biopharma Inc

AzurRx BioPharma Inc through its subsidiary is engaged in the research and development of non-systemic biologics for the treatment of patients with gastrointestinal disorders. Its products under development includes MS1819 and AZ1101.

$3.77  -0.07 (-1.82%)
As of 09/17/2021 15:59:56 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  10/11/2016
Outstanding shares:  93,261,897
Average volume:  3,039,895
Market cap:   $358,125,684
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    05502L204
ISIN:        US05502L2043
Sedol:      BNYDNR3
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy